Division of Molecular Medicine, Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada; Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Division of Medical Genetics, Department of Pediatrics, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Québec, Canada.
J Lipid Res. 2021;62:100128. doi: 10.1016/j.jlr.2021.100128. Epub 2021 Sep 28.
The cytosolic-oriented glucosylceramide (GlcCer) synthase is enigmatic, requiring nascent GlcCer translocation to the luminal Golgi membrane to access glycosphingolipid (GSL) anabolic glycosyltransferases. The mechanism by which GlcCer is flipped remains unclear. To investigate the role of GlcCer-binding partners in this process, we previously made cleavable, biotinylated, photoreactive GlcCer analogs in which the reactive nitrene was closely apposed to the GlcCer head group, while maintaining a C16-acyl chain. GlcCer-binding protein specificity was validated for both photoprobes. Using one probe, XLB, here we identified ATP-binding cassette (ABC) transporters ABCA3, ABCB4, and ABCB10 as unfractionated microsomal GlcCer-binding proteins in DU-145 prostate tumor cells. siRNA knockdown (KD) of these transporters differentially blocked GSL synthesis assessed in toto and via metabolic labeling. KD of ABCA3 reduced acid/neutral GSL levels, but increased those of LacCer, while KD of ABCB4 preferentially reduced neutral GSL levels, and KD of ABCB10 reduced levels of both neutral and acidic GSLs. Depletion of ABCA12, implicated in GlcCer transport, preferentially decreased neutral GSL levels, while ABCB1 KD preferentially reduced gangliosides, but increased neutral GSL Gb. These results imply that multiple ABC transporters may provide distinct but overlapping GlcCer and LacCer pools within the Golgi lumen for anabolism of different GSL series by metabolic channeling. Differential ABC family member usage may fine-tune GSL biosynthesis depending on cell/tissue type. We conclude that ABC transporters provide a new tool for the regulation of GSL biosynthesis and serve as potential targets to reduce selected GSL species/subsets in diseases in which GSLs are dysregulated.
细胞质定位的葡萄糖神经酰胺(GlcCer)合成酶是一个谜,需要新生的 GlcCer 易位到腔面高尔基体膜,才能与糖脂(GSL)合成糖基转移酶相互作用。GlcCer 翻转的机制尚不清楚。为了研究 GlcCer 结合伴侣在这个过程中的作用,我们之前合成了可切割的、生物素化的、光反应性的 GlcCer 类似物,其中反应性氮烯紧密地与 GlcCer 头部基团相邻,同时保持 C16-酰基链。两种光探针都验证了 GlcCer 结合蛋白的特异性。使用其中一个探针 XLB,我们在这里鉴定了 ATP 结合盒(ABC)转运蛋白 ABCA3、ABCB4 和 ABCB10 作为未分级微粒体 GlcCer 结合蛋白,存在于 DU-145 前列腺肿瘤细胞中。这些转运蛋白的 siRNA 敲低(KD)差异地阻断了总糖脂合成和代谢标记评估的糖脂合成。ABCA3 的 KD 降低了酸/中性糖脂的水平,但增加了 LacCer 的水平,而 ABCB4 的 KD 优先降低了中性糖脂的水平,ABCB10 的 KD 降低了中性和酸性糖脂的水平。GlcCer 转运中涉及的 ABCA12 的耗竭优先降低了中性糖脂的水平,而 ABCB1 的 KD 优先降低了神经节苷脂,但增加了中性糖脂 Gb。这些结果表明,多个 ABC 转运蛋白可能在高尔基体腔中为不同 GSL 系列的合成代谢提供不同但重叠的 GlcCer 和 LacCer 池,通过代谢通道化。ABCB 家族成员的差异使用可能根据细胞/组织类型微调 GSL 生物合成。我们得出结论,ABC 转运蛋白为 GSL 生物合成的调节提供了新的工具,并可能成为在 GSL 失调的疾病中减少特定 GSL 种类/亚类的潜在靶点。